US President Obama's budget request includes $911 billion for HHS and $4 billion for FDA in FY2011

2 February 2010

US Department of Health and Human Services Secretary Kathleen Sebelius highlighted critical investments in President Barack Obama's 2011 HHS budget that will protect the health and safety of America's families. Overall, the budget includes a total of $911 billion for the HHS in the next fiscal year.

'Under this budget, we will provide the health and human services that Americans depend on more effectively, slashing waste and focusing programs on results. And we'll make many of the necessary investments our country has been putting off for years, including investments in fighting health care fraud, strengthening our public health infrastructure, and getting serious about health and wellness,' said Ms Sebelius, noting: 'This budget is a big step toward a healthier, stronger America.'

The President's budget helps build the foundation for health insurance reform. The budget strengthens the health care system and improves access to care by investing $995 million to address the shortage of health care providers in underserved areas, increasing funding to expand services at Health Centers by $290 million and allocating nearly $80 million for work to spread the adoption and use of health information technology.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics